Publikationen von Norbert Galldiks

Dohmen, C.; Galldiks, N.; Bosche, B.; Kracht, L.; Graf, R.: The severity of ischemia determines and predicts malignant brain edema in patients with large middle cerebral artery infarction. Cerebrovascular Diseases 33 (1), S. 1 - 7 (2012)

Galldiks, N.; Dunkl, V.; Kracht, L. W.; Vollmar, S.; Jacobs, A. H.; Fink, G. R.; Schroeter, M.: Volumetry of [C-11]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma. Molecular Imaging 11 (6), S. 516 - 527 (2012)

Galldiks, N.; von Tempelhoff, W.; Kahraman, D.; Kracht, L. W.; Vollmar, S.; Fink, G. R.; Schroeter, M.; Goldbrunner, R.; Schmidt, M.; Maarouf, M.: 11C-methionine positron emission tomographic imaging of biologic activity of a recurrent glioblastoma treated with stereotaxy-guided laser-induced interstitial Thermotherapy. Molecular Imaging 11 (4), S. 265 - 271 (2012)

Galldiks, N.; Kracht, L. W.; Dunkl, V.; Ullrich, R. T.; Vollmar, S.; Jacobs, A. H.; Fink, G. R.; Schroeter, M.: Imaging of non-or very subtle contrast-enhancing malignant gliomas with [ 11C]-methionine positron emission tomography. Molecular Imaging 10 (6), S. 453 - 459 (2011)

Rueger, M. A.; Ameli, M.; Li, H.; Winkeler, A.; Rueckriem, B.; Vollmar, S.; Galldiks, N.; Hesselmann, V.; Fraefel, C.; Wienhard, K. et al.; Heiss, W.-D.; Jacobs, A. H.: FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas. Molecular Imaging and Biology 13 (3), S. 547 - 557 (2011)

Dohmen, C.; Galldiks, N.; Moeller-Hartmann, W.; Fink, G. R.; Timmermann, L.: Sequential escalation of therapy in "malignant" cerebral venous and sinus thrombosis. Neurocritical Care 12 (1), S. 98 - 102 (2010)

Galldiks, N.; Kracht, L. W.; Berthold, F.; Miletic, H.; Klein, J. C.; Herholz, K.; Jacobs, A. H.; Heiss, W.-D.: [11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors. Journal of Neuro-Oncology 96 (2), S. 231 - 239 (2010)

Galldiks, N.; Kracht, L. W.; Burghaus, L.; Ullrich, R. T.; Backes, H.; Brunn, A.; Heiss, W.-D.; Jacobs, A. H.: Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. Molecular Imaging 9 (1), S. 40 - 46 (2010)

Galldiks, N.; Schroeter, M.; Fink, G. R.; Kracht, L. W.: PET imaging of a butterfly glioblastoma. Clinical Nuclear Medicine 35 (1), S. 49 - 50 (2010)

Galldiks, N.; Ullrich, R.; Schroeter, M.; Fink, G. R.; Kracht, L. W.: Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. European Journal of Nuclear Medicine and Molecular Imaging 37 (1), S. 84 - 92 (2010)

Galldiks, N.; Ullrich, R.; Schroeter, M.; Fink, G. R.; Kracht, L. W.: Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen. Journal of Neuro-Oncology 93 (3), S. 425 - 430 (2009)

Galldiks, N.; Thiel, A.; Haense, C.; Fink, G. R.; Hilker, R.: C-11-Flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with Stiff Person Syndrome. Journal of Neurology 255 (9), S. 1361 - 1364 (2008)

Galldiks, N.; Nolden-Hoverath, S.; Kosinski, C. M.; Stegelmeyer, U.; Schmidt, S.; Dohmen, C.; Kuhn, J.; Gerbershagen, K.; Bewermeyer, H.; Walger, P. et al.; Biniek, R.; Neveling, M.; Jacobs, A. H.; Haupt, W. F.: Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin. Neurocritical Care 6 (1), S. 30 - 34 (2007)

Burghaus, L.; Hilker, R.; Dohmen, C.; Bosche, B.; Winhuisen, L.; Galldiks, N.; Szelies, B.; Heiss, W.-D.: Early electroencephalography in acute ischemic stroke: Prediction of a malignant course? Clinical Neurology and Neurosurgery 109 (1), S. 45 - 49 (2007)

Galldiks, N.; Kracht, L. W.; Burghaus, L.; Thomas, A.; Jacobs, A. H.; Heiss, W.-D.; Herholz, K.: Use of C-11-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging 33 (5), S. 516 - 524 (2006)

Heneka, M. T.; Ramanathan, M. A.; Jacobs, A. H.; Dumitrescu-Ozimek, L.; Bilkei-Gorzo, A.; Debeir, T.; Sastre, M.; Galldiks, N.; Zimmer, A.; Hoehn, M. et al.; Heiss, W.-D.; Klockgether, T.; Staufenbiel, M.: Locus Ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. Journal of Neuroscience 26 (5), S. 1343 - 1354 (2006)

Thomas, A.; Klein, J. C.; Galldiks, N.; Grond, M.; Jacobs, A. H.: Multitracer PET imaging in Heidenhain variant of Creutzfeldt-Jakob disease. Journal of Neurology 253 (2), S. 258 - 260 (2006)

Jacobs, A. H.; Thomas, A.; Kracht, L. W.; Li, H. F.; Dittmar, C.; Garlip, G.; Galldiks, N.; Klein, J. C.; Sobesky, J.; Hilker, R. et al.; Vollmar, S.; Herholz, K.; Wienhard, K.; Heiss, W.-D.: F-18-fluoro-L-thymidine and C-11-methylmethionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine 46 (12), S. 1948 - 1958 (2005)

Dohmen, C.; Bosche, B.; Galldiks, N.; Kracht, L.; Sobesky, J.; Graf, R.; Heiss, W.-D.: Severity of ischemia determines space-occupying brain edema after middle cerebral artery infarction. Stroke 36 (2), S. 440 - 440 (2005)

Galldiks, N.; Heneka, M.; Winkeler, A.; Rüger, M.A.; Bauer, B.; Küstermann, E.; Hoehn, M.; Heiss, W.-D.; Jacobs, A.: MicroPET-based imaging of endogenous gene expression in transgenic APP23 mice. Molecular Imaging 4, S. 336 - 336 (2005)